Browsing Tag
Arbli
3 posts
BlinkRx collaboration positions Scienture’s Arbli for nationwide patient access in the $250+ million losartan market
Discover how Scienture and BlinkRx are expanding nationwide access to Arbli, the first FDA-approved liquid losartan, and what it means for the $250M hypertension market.
Scienture starts commercial rollout of Arbli, the first FDA-approved losartan oral suspension
Find out how Scienture is changing the hypertension treatment market with the FDA-approved Arbli losartan oral suspension.
Hypertension breakthrough: Scienture launches first FDA-approved liquid losartan Arbli through U.S. distributors
Discover how Scienture’s Arbli is redefining hypertension treatment as the first FDA-approved liquid losartan and what it signals for SCNX investors.